Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases. Sanofi will pay $129 per share in cash for the US ...

Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.

Nature Immunology is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology. Priority is given to work that provides fundamental ...

Sanofi has agreed to acquire US-based Blueprint Medicines for an equity value of $9.1bn to bolster its immunology pipeline with rare disease treatments. The acquisition includes Ayvakit/Ayvakyt ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and psychiatric disorders.

Mingyang Song, MBBS, ScD, discusses the link between ultraprocessed foods and cancer risk, emphasizing nutrition's role in prevention. During an interview at the American Association for Cancer ...

AbbVie Q1 sales rose 8.4% to $13.34 billion, and adjusted EPS grew 6.5% to $2.46, beating Wall Street estimates. Skyrizi sales jumped 70.5% to $3.43 billion, and Rinvoq sales climbed 57.2% to $1. ...

A study published in Frontiers explores the microbial diversity within hospital sink drains across multiple wards over a year-long period, focusing on bacterial communities, species identification, ...

A recent article in Nature Communications, by Dr. David Sancho and others, found that a type 1 dendritic cell vaccine is critical in eliciting a robust immune response and leads to immune memory. Type ...

Immunology continues to be one of the most active areas for drug research as the field aims to bring patients new ways to eliminate the antibodies driving autoimmune disease, but in a manner that ...

Sanofi is building on its immunology ambitions by acquiring an early clinical Dren Bio drug candidate that offers a potential first-in-class approach to autoimmune disorders such as lupus. It’s ...

Sanofi to acquire Dren Bio's immunology unit. By Reuters. March 20, 2025 6:42 AM UTC Updated March 20, 2025. A logo of Sanofi is seen at the Sanofi's Doliprane ...